{
    "code": "60001056",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=60001056",
    "time": "2019-08-30 03:18:40",
    "許可證字號": "衛部菌疫輸字第001056號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "111\/07\/14",
    "發證日期": "106\/07\/14",
    "許可證種類": "菌　疫",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA06000105601",
    "中文品名": "兆科注射劑20毫克\/毫升",
    "英文品名": "Darzalex Concentrate for solution for infusion 20mg\/ml",
    "適應症": "DARZALEX適用於：\r\n與bortezomib、melphalan及prednisone併用，治療不適合接受自體幹細胞移植的新診斷多發性骨髓瘤成人病人。\r\n與lenalidomide加dexamethasone或與bortezomib加dexamethasone併用，治療先前曾接受至少一種療法治療的多發性骨髓瘤成人病人。\r\n做為單一治療用藥，治療先前曾接受治療(包括一種蛋白酶體抑制劑與一種免疫調節劑)且在最後一種療法之治療下出現疾病惡化現象的復發性或難治性多發性骨髓瘤成人病人。",
    "劑型": "27D注射液劑",
    "包裝": "100毫克\/5毫升、400毫克\/20毫升玻璃小瓶裝 100支以下盒裝",
    "": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "-->\r\n                    \r\n                        \r\n                            標籤、仿單及包裝加註": [
        ""
    ],
    "藥品類別": "05限由醫師使用",
    "主成分略述": "Daratumumab",
    "主製造廠": {
        "申請商名稱": "1507401100  嬌生股份有限公司",
        "申請商地址": "台北市中山區民生東路三段2號10樓及11樓",
        "主製造廠": "",
        "製造廠名稱": "FCH0274000  CILAG AG"
    },
    "CCC號列": "",
    "藥理治療分類": "",
    "次製造廠": [
        {
            "製造廠名稱": "6132061151  裕利股份有限公司",
            "製造廠廠址": "桃園市大園區和平里1鄰開和路91號",
            "製造廠公司地址": "",
            "製造廠國別": "TAIWAN",
            "製程": "二級包裝廠(委託貼標及置入仿單)"
        },
        {
            "製造廠名稱": "6605071926  久裕企業股份有限公司",
            "製造廠廠址": "桃園市桃園區大林里興邦路43巷2之1號4樓，3樓B區，1樓A區",
            "製造廠公司地址": "",
            "製造廠國別": "",
            "製程": "二級包裝廠(委託貼標及置入仿單)"
        },
        {
            "製造廠名稱": "FIE0080000  JANSSEN SCIENCES IRELAND UC",
            "製造廠廠址": "BARNAHELY, RINGASKIDDY, CO.CORK, IRELAND",
            "製造廠公司地址": "",
            "製造廠國別": "IRELAND",
            "製程": "原料藥製造廠"
        },
        {
            "製造廠名稱": "FUS0785100  BIOGEN INC.",
            "製造廠廠址": "5000 DAVIS DRIVE, RESEARCH TRIANGLE PARK, NC 27709-4627, USA",
            "製造廠公司地址": "",
            "製造廠國別": "UNITED STATES",
            "製程": "原料藥製造廠"
        }
    ],
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1013006400",
            "成分名稱": "Daratumumab",
            "含量描述": "",
            "含量": "100.0000000000",
            "單位": "MG"
        },
        {
            "成分類別": "主成分",
            "成分代碼": "1013006400",
            "成分名稱": "Daratumumab",
            "含量描述": "",
            "含量": "400.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "[打樣版] (Chi) PI_Darzalex_USPI Jun 2018_v1803_2019-06-18_20190514-108-06-25(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001056&Seq=007&Type=9"
        },
        {
            "title": "兆科注射劑20毫克毫升-仿單v1803新址-20190416-108-06-13.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001056&Seq=006&Type=9"
        },
        {
            "title": "Darzalex 外盒_2019-03-29-108-03-29(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001056&Seq=015&Type=8"
        },
        {
            "title": "0222-Darzalex label 400mg_Vetter_37791A_1-107-05-10.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001056&Seq=014&Type=8"
        },
        {
            "title": "0222-Darzalex label 400mg_Cilag_37791A-107-05-10.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001056&Seq=013&Type=8"
        },
        {
            "title": "0222-Darzalex label 100mg_Vetter_37789A_1-107-05-10.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001056&Seq=012&Type=8"
        },
        {
            "title": "0222-Darzalex label 100mg_Cilag_37793A_1-107-05-10.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001056&Seq=011&Type=8"
        }
    ]
}